Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

9 Dec 2011 08:43

RNS Number : 6782T
CATCo Reinsurance Opps Fund Ltd
09 December 2011
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL

 

CATCo Reinsurance Opportunities Fund Ltd.

 

("CATCo" or the "Company")

 

Net Asset Value(s) and Placing Price of new C-shares

 

Net Asset Value(s)

 

 

CATCo Investment Management Ltd, as Company Secretary, announces the unaudited net asset values of the Company's Ordinary Shares and C-shares of USD$1.0801 and USD$1.0314, respectively, as at the close of business on 30 November 2011.

 

On the 15 November 2011 the Board declared a final dividend of USD$0.051 for both the Ordinary and C-shares. The record date was 2 December 2011 and both the Ordinary and C-shares went ex-dividend on 30 November 2011.

 

Issue of new C-shares

 

Further to the announcement of 22 November, CATCo is pleased to announce the placing price of the new C shares to be issued under the Second Closing. A placing price of USD$1.0520 per C-share was calculated as the net asset value per C-share as at the close of business on 30 November 2011 plus 2 per cent (the "Placing Price"). The issue of new equity is a result of the placing commitments from institutional investors of USD$125 million which were announced to the market on 22 November 2011 (the "Placing").

 

The Placing Price for the new tranche of C-shares is calculated below taking into consideration the Company's dividend declaration:

 

C-share NAV as at 30 November 2011 (Ex-dividend)

USD$1.0314

Issue price for Placing C-share

USD$1.0520

Number of New C-shares to be issued

118,821,292

 

These 118,821,292 new C-shares form the Second Closing of a wider placing of up to 400 million New Shares to be admitted to trading on the Specialist Fund Market ("SFM"), which opened on 18 May 2011.

 

Timetable for the Second Closing

 

Admission of the second tranche of C-shares to trading on the London Stock Exchange's Specialist Fund Market

 

16 December 2011

CREST accounts to be credited in respect of the Depository Interests representing the second tranche of C-shares

 

16 December 2011

Admission of the second tranche of C-shares and the existing Ordinary Shares to trading on the Bermuda Stock Exchange

 

16 December 2011

 

Application has been made for these new C-shares to be admitted to trading on the London Stock Exchange's Specialist Fund Market. Trading is expected to commence on 16 December 2011. On Admission the Company will have in issue 87,642,000 Ordinary Shares and 244,118,029 C-shares.

 

Conversion of Second Closing C-shares into Ordinary Shares

 

In respect of the C-shares issued at both the First Closing and to be issued at the Second Closing, it is intended that such C-shares will convert into Ordinary Shares shortly after the date on which the Side Pocket Investment attributable to the New Zealand and the Japanese earthquakes is no longer designated as such and the relevant SP Shares held by the Company in respect of such exposures have converted back into Master Fund Shares.

 

Defined terms used in this Announcement shall have the same meaning as ascribed to them in the Company's Supplementary Prospectus dated 1 December 2011 and Prospectus dated 18 May 2011.

 

For further information contact:

 

CATCo Reinsurance Opportunities Fund Ltd

 

Jason Bibb (Chief Operating Officer)

Mark Way (Corporate Communications Director)

 

 

 

+1 (441) 531 2227

+44 (0) 7786 116 991

Numis Securities Limited

 

David Benda (Corporate Broking)

Hugh Jonathan (Corporate Finance)

Will Kostoris (Corporate Finance)

0207 260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEVKLBBFLFZFBL
Date   Source Headline
28th May 20194:00 pmRNSDirector/PDMR Shareholding
23rd May 20194:31 pmRNSResult of Annual General Meeting
20th May 20197:00 amRNSNet Asset Value(s)
13th May 20196:09 pmRNSHolding(s) in Company
29th Apr 20197:00 amRNSNet Asset Value(s)
23rd Apr 20197:00 amRNSFinal Results
15th Apr 20197:00 amRNSUpdate re government enquiry at Markel CATCo
4th Apr 20197:00 amRNSNet Asset Value(s)
26th Mar 201912:15 pmRNSResult of Meeting
14th Mar 20197:00 amRNSNet Asset Value(s)
11th Mar 20193:30 pmRNSPartial waiver of management fee re side pockets
28th Feb 20195:48 pmRNSCirc re. restructuring of Company & Class Meetings
26th Feb 20191:53 pmRNSDirectorate Change
19th Feb 201912:00 pmRNSPortfolio Update
7th Feb 20197:00 amRNSNet Asset Value(s) and Portfolio Update
21st Jan 20197:00 amRNSUpdate on Investment Manager
10th Jan 20192:03 pmRNSDirector/PDMR Shareholding
10th Jan 20192:02 pmRNSDirector/PDMR Shareholding
4th Jan 201912:15 pmRNSHolding(s) in Company
3rd Jan 201911:44 amRNSDirector/PDMR Shareholding
21st Dec 20187:00 amRNSNet Asset Value(s)
18th Dec 20183:30 pmRNSPortfolio Update
18th Dec 20183:30 pmRNSDiscount control measures
17th Dec 20184:30 pmRNSHolding(s) in Company
10th Dec 20187:00 amRNSHolding(s) in Company
7th Dec 20184:35 pmRNSPrice Monitoring Extension
7th Dec 20187:00 amRNSPortfolio Update
7th Dec 20187:00 amRNSAnnouncement regarding Markel CATCo
22nd Nov 20182:05 pmRNSSecond Price Monitoring Extn
22nd Nov 20182:00 pmRNSPrice Monitoring Extension
22nd Nov 20187:00 amRNSNet Asset Value(s) & Portfolio Update
18th Oct 20187:00 amRNSNet Asset Value and Portfolio Update
1st Oct 20187:00 amRNSDirector/PDMR Shareholding
27th Sep 20184:05 pmRNSHolding(s) in Company
24th Sep 20181:25 pmRNSDirector/PDMR Shareholding
24th Sep 20181:23 pmRNSDirector/PDMR Shareholding
21st Sep 201811:05 amRNSTransaction in Own Shares
20th Sep 20187:00 amRNSNet Asset Value(s)
29th Aug 20183:55 pmRNSShare interests acquisition by CEO of Inv Manager
29th Aug 20183:51 pmRNSDirector/PDMR Shareholding
29th Aug 201812:08 pmRNSDirector/PDMR Shareholding
20th Aug 20187:00 amRNSNet Asset Value(s)
17th Aug 20187:00 amRNSHalf-year Report
16th Jul 20182:44 pmRNSNet Asset Value(s)
10th Jul 20182:57 pmRNSHolding(s) in Company
21st Jun 20185:09 pmRNSReplacement Share Interest Acquisition CEO Inv Mgr
21st Jun 20183:10 pmRNSShare Interests Acquisition by CEO of Inv Manager
21st Jun 201811:35 amRNSShare Interests Acquisition by CEO of Inv Manager
20th Jun 20181:42 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.